Conference Coverage

Apixaban prevails in study of 163,000 DOAC users


 

REPORTING FROM ACC 2018

SOURCE: Deitelzweig SB. ACC 2018.

Next Article:

Transcatheter valves underperform for native aortic regurgitation

Related Articles